Dmitry Stakheev

The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro

Dmitry Stakheev, Pavla Táborská, Zuzana Střížová et al. · Scientific Reports · 2019 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functions

Gianluca Mucciolo, Claudia Curcio, Cecilia Roux et al. · Proceedings of the National Academy of Sciences · 2021 · 49 citations · Full text

Life Sciences, Immunology, Oncology +17

<I>In Vivo</I> Targeting of Cutaneous Melanoma Using an Melanoma Stimulating Hormone-Engineered Human Protein Cage with Fluorophore and Magnetic Resonance Imaging Tracers

Luca Vannucci, Elisabetta Falvo, Cristina Maria Failla et al. · Journal of Biomedical Nanotechnology · 2014 · 29 citations

Pharmacy, Oncology, Pharmaceutics +17

The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients

Zuzana Střížová, Martin Snajdauf, Dmitry Stakheev et al. · Journal of Cancer Research and Clinical Oncology · 2020 · 22 citations · Full text

Medicine, Immunology, Oncology +14

NK and T cells with a cytotoxic/migratory phenotype accumulate in peritumoral tissue of patients with clear cell renal carcinoma

Zuzana Střížová, Pavla Táborská, Dmitry Stakheev et al. · Urologic Oncology Seminars and Original Investigations · 2019 · 20 citations

Medicine, Immunology, Oncology +12